Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 31 Advanced Solid Tumors 25 Advanced Solid Tumor 24 Carcinoma, Non-Small-Cell Lung 20 Neoplasms 15 Solid Tumor 12 Prostatic Neoplasms 12 Multiple Myeloma 12 Neoplasm Metastasis 11 Recurrence 10 Pancreatic Neoplasms 10 Small Cell Lung Carcinoma 9 Ovarian Neoplasms 9 Lung Neoplasms 9 Stomach Neoplasms 8 Melanoma 8 Lymphoma, Large B-Cell, Diffuse 8 Leukemia, Myeloid, Acute 8 Carcinoma, Hepatocellular 8 Triple Negative Breast Neoplasms 7 Sarcoma 7 Colorectal Neoplasms 7 Uterine Cervical Neoplasms 6 Solid Tumors 6 Carcinoma, Transitional Cell 5 Advanced Solid Tumour 5 Squamous Cell Carcinoma of Head and Neck 4 Nasopharyngeal Carcinoma 4 Myelodysplastic Syndromes 4 Lymphoma 4

Interventions

Fentanyl 13 Zoledronic Acid 8 Ibandronic Acid 8 nabiximols 6 Oxycodone 6 Tapentadol 5 Morphine 4 Hydromorphone 4 Cryotherapy 4 Cryosurgery 4 alvimopan 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 resiniferatoxin 2 cabozantinib 2 Tetrodotoxin 2 Radiation 2 Prednisone 2 Naloxone 2 Diclofenac 2 Analgesics, Opioid 2 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2 ziconotide 1 oxycodone naloxone combination 1 imisopasem manganese 1 fulranumab 1 Xylitol 1 Ultracet 1 Transdermal Patch 1 Therapeutics 1 Sufentanil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Pain × Injections × Clear all

NCT01482936 2015-08-11

Pharmacokinetic (PK) Study of OxyNorm Injections in Chinese Patient

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 1 Completed

Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡